Maccura Biotechnology's new coronavirus detection product obtains registration certificate

2020-05-18
|
ChinaMedical

Maccura Biotechnology announced that the company recently received the Medical Device Registration Certificate issued by the State Drug Administration.


The registered products are the new coronavirus (2019-nCoV) IgM antibody detection kit (direct chemiluminescence method) and the new coronavirus (2019-nCoV) IgG antibody detection kit (direct chemiluminescence method).


RELATED ARTICLES

JD Health and AstraZeneca start strategic cooperation
2020-11-18
|
Medical care , Pharmaceutical

China Isotope & Radiation Corporation and Bayer agree to introduce Xofigo into China
2020-09-02
|
Pharmaceutical , Medical care

Xuanzhu Biopharm closes RMB 800 mln Series A
2020-08-27
|
Pharmaceutical , PEVC

Anti-body R&D company Escugen closes Pre-A raising tens of millions in RMB
2020-08-27
|
PEVC , Biotech , Pharmaceutical

China's first COVID-19 vaccine produced by insect cells obtained clinical trial approval
2020-08-24
|
Pharmaceutical , Vaccine , Covid-19 , Biotech

D2M Biotherapeutics completes $10 million Pre-A round of financing
2020-08-23
|
PEVC , Pharmaceutical , Biotech

China's first mRNA Covid-19 vaccine approved for clinical trials
2020-06-29
|
Covid-19 , Biotechnology

Bio-Thera: BAT1308 injection received notification of clinical trial
2020-05-28
|
Healthcare , Pharmaceutical

New drug application of Paimpril accepted by State Drug Administration
2020-05-26
|
Biopharmaceutical , Medical care

Hengrui Medicine: Remazolam Tosylate for Injection Obtained Clinical Trial Notice
2020-05-14
|
Pharmaceutical
China SDG